Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database

被引:1
|
作者
Bentzel, Sara [1 ,2 ]
Ljungman, Charlotta [1 ,2 ]
Hjerpe, Per [3 ,4 ]
Schioler, Linus [5 ]
Manhem, Karin [6 ]
Bostrom, Kristina Bengtsson
Kahan, Thomas [7 ]
Mourtzinis, Georgios [1 ,8 ]
机构
[1] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Inst Med, Bla Straket 5B Wallenberglab SU, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Cardiol, Bla Straket 3, S-41346 Gothenburg, Sweden
[3] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Gothenburg, Sweden
[4] Reg Halsan R&D Ctr, Skaraborg Primary Care, Skovde, Sweden
[5] Univ Gothenburg, Inst Med, Sch Publ Hlth & Community Med, Occupat & Environm Med,Sahlgrenska Acad, Gothenburg, Sweden
[6] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Sahlgrenska Acad,Dept Mol & Clin Med, Gothenburg, Sweden
[7] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden
[8] Sahlgrens Univ Hosp, Dept Med & Emergency Molndal, Molndal, Sweden
关键词
Coronary artery disease; Risk factors; Secondary prevention; Treatment adherence; EUROPEAN-SOCIETY; GUIDELINES; RISK; HYPERTENSION; MANAGEMENT;
D O I
10.1093/eurjpc/zwad389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Most studies of treatment adherence after acute coronary syndrome (ACS) are based on prescribed drugs and lack long-term follow-up or consecutive data on risk factor control. We studied the long-term treatment adherence, risk factor control, and its association to recurrent ACS and death.Methods and results We retrospectively included 3765 patients (mean age 75 years, 40% women) with incident ACS from 1 January 2006 until 31 December 2010 from the Swedish Primary Care Cardiovascular Database of Skaraborg. All patients were followed until 31 December 2014 or death. We recorded blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), recurrent ACS, and death. We used data on dispensed drugs to calculate the proportion of days covered for secondary prevention medications. Cox regressions were used to analyse the association of achieved BP and LDL-C to recurrent ACS and death. The median follow-up time was 4.8 years. The proportion of patients that reached BP of <140/90 mm Hg was 58% at Year 1 and 66% at Year 8. 65% of the patients reached LDL-C of <2.5 mmol/L at Year 1 and 56% at Year 8; however, adherence to statins varied from 43% to 60%. Only 62% of the patients had yearly measured BP, and only 28% yearly measured LDL-C. Systolic BP was not associated with a higher risk of recurrent ACS or death. Low-density lipoprotein cholesterol of 3.0 mmol/L was associated with a higher risk of recurrent ACS {hazard ratio [HR] 1.19 [95% confidence interval (CI) 1.00-1.40]} and death HR [1.26 (95% CI 1.08-1.47)] compared with an LDL-C of 1.8 mmol/L.Conclusion This observational long-term real-world study demonstrates low drug adherence and potential for improvement of risk factors after ACS. Furthermore, the study confirms that uncontrolled LDL-C is associated with adverse outcome even in this older population.Lay summary In this real-world retrospective observational study, we followed 3765 elderly patients for up to 8 years after incident acute coronary syndrome.center dot Only a low proportion of the studied population had yearly measured blood pressure and cholesterol, a low proportion had satisfied risk factor control (blood pressure and cholesterol), and adherence to secondary prevention medication was low.center dot In this elderly population (mean age 75 years), higher levels of low-density lipoprotein cholesterol were associated with a higher risk of recurrent coronary event and death.
引用
收藏
页码:812 / 821
页数:10
相关论文
共 50 条
  • [1] Long-term risk factor control after acute coronary syndrome; results from the Swedish primary care cardiovascular database
    Bentzel, S.
    Ljungman, C.
    Hjerpe, P.
    Schioler, L.
    Manhem, K.
    Mourtzinis, G.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1268 - 1268
  • [2] CARDIOVASCULAR OUTCOME IN TREATMENT RESISTANT HYPERTENSION - RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE
    Oshchepkova, E.
    Zhernakova, I.
    Chazova, I.
    Shalnova, S.
    Boytsov, S.
    Konradi, A.
    Shlyakhto, E.
    Rotar, O.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E147 - E147
  • [3] CARDIOVASCULAR OUTCOME IN TREATMENT RESISTANT HYPERTENSION - RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE
    Holmqvist, L.
    Bostrom, K. Bengtsson
    Kahan, T.
    Schioler, L.
    Hasselstrom, J.
    Hjerpe, P.
    Wettermark, B.
    Manhem, K.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E147 - E147
  • [4] Long-term effectiveness of secondary prevention in patients with acute coronary syndrome
    Ryzhikova, I. B.
    Pogosova, N. V.
    Koltunov, I. E.
    Pozdnyakov, Yu. M.
    Vygodin, V. A.
    [J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (07): : 59 - 63
  • [5] Long-term outcomes of icatibant in the real-world setting: results from the Icatibant outcome survey
    Longhurst, H.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Maurer, M.
    Fabien, V
    Andresen, I
    [J]. ALLERGY, 2015, 70 : 58 - 58
  • [6] Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD)
    Holmqvist, Lina
    Bostrom, Kristina B.
    Kahan, Thomas
    Schioler, Linus
    Hasselstrom, Jan
    Hjerpe, Per
    Wettermark, Bjorn
    Manhem, Karin
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 (02) : 402 - 409
  • [7] Reinforcing a continuum of care: In-hospital initiation of long-term secondary prevention following acute coronary syndromes
    Rockson, Stanley G.
    Degoma, Emil M.
    Fonarow, Gregg C.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (05) : 375 - 388
  • [8] Reinforcing a Continuum of Care: In-Hospital Initiation of Long-Term Secondary Prevention Following Acute Coronary Syndromes
    Stanley G. Rockson
    Emil M. deGoma
    Gregg C. Fonarow
    [J]. Cardiovascular Drugs and Therapy, 2007, 21 : 375 - 388
  • [9] Achievement of long-term lipid targets in a cohort of patients with acute coronary syndrome in real-world clinical practice
    Conde, C. Baldeon
    Martinez, N. Royuela
    Ibarbia, C. Garcia
    Ruiz, A. R. Guerra
    Miguel, I. Olavarri
    Belaustegui, M. Cobo
    Lavin, B. Alio
    Vilchez, F. J. Gonzalez
    Hernandez, J. M. de la Torre
    Hernandez, J. L. Hernandez
    [J]. REVISTA CLINICA ESPANOLA, 2023, 223 (04): : 223 - 230
  • [10] ACUTE CORONARY SYNDROMES Acute coronary syndromes: key role of rehabilitation and primary care in long term secondary prevention
    Dalal, Hasnain M.
    Wingham, Jenny
    Taylor, Rod S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351